Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-17 Sale | 2024-04-19 6:06 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 9,827 | $29.06 | $285,554 | 347,119 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:05 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 8,280 | $29.06 | $240,602 | 377,650 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:01 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 12,253 | $29.06 | $356,049 | 359,456 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:59 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 10,115 | $29.06 | $293,923 | 451,627 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:57 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 34,079 | $29.06 | $990,269 | 1,052,879 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:18 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,689 | $31.18 | $115,023 | 371,709 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:16 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,053 | $31.18 | $32,833 | 461,742 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:14 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,807 | $31.18 | $149,882 | 1,086,958 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:21 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,930 | $36.15 | $105,920 | 320,420 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:18 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,134 | $36.15 | $77,144 | 301,968 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:16 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 2,221 | $36.15 | $80,289 | 330,952 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:14 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 2,146 | $36.15 | $77,578 | 407,817 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:11 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 13,454 | $36.15 | $486,362 | 931,231 (Direct) | View |
| 2024-01-26 Sale | 2024-01-29 4:12 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,027 | $37.92 | $114,778 | 304,102 (Direct) | View |
| 2024-01-26 Sale | 2024-01-29 4:11 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 10,101 | $37.92 | $383,012 | 89,899 (Direct) | View |
| 2024-01-18 Sale | 2024-01-19 4:04 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 424 | $41.03 | $17,397 | 333,173 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 4:34 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,515 | $41.83 | $147,023 | 323,350 (Direct) | View |
| 2024-01-05 Sale | 2024-01-09 4:20 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,297 | $38.59 | $50,051 | 409,963 (Direct) | View |
| 2024-01-05 Sale | 2024-01-09 4:18 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 3,824 | $38.59 | $147,568 | 944,685 (Direct) | View |
| 2023-12-01 Sale | 2023-12-05 4:30 pm | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 12,350 | $39.73 | $490,697 | 88,658 (Direct) | View |
| 2023-12-01 Sale | 2023-12-05 4:28 pm | Immunovant Inc. | IMVT | Pande Atul Director | 12,350 | $39.73 | $490,668 | 103,158 (Indirect Direct) | View |
| 2023-12-01 Sale | 2023-12-05 4:25 pm | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 12,700 | $39.73 | $504,567 | 109,808 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 2:55 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 16,217 | $32.78 | $531,581 | 948,509 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 2:51 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,055 | $32.78 | $132,920 | 326,865 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 2:47 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 3,265 | $32.78 | $107,024 | 411,260 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 2:45 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,265 | $32.78 | $107,024 | 333,597 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 2:41 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,252 | $32.78 | $106,598 | 307,129 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-02 Option Award | 2024-04-04 4:54 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 15,945 | $0 | 104,603 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:50 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 15,945 | $0 | 129,700 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:48 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 15,945 | $0 | 125,753 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:46 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Pande Atul Director | 15,945 | $0 | 119,103 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:44 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Torti Frank Director | 170,567 | $0 | 685,841 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:39 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 123,701 | $0 | 223,701 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:37 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 123,701 | $0 | 425,669 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:34 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 123,701 | $0 | 454,653 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:31 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 123,701 | $0 | 213,600 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:29 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 123,701 | $0 | 531,518 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:27 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 123,701 | $0 | 444,121 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:23 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 361,201 | $0 | 1,292,432 (Direct) | View |
Ownership | 2024-01-16 07:29 am | N/A N/A | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer* | 0 | $0 | 250,000 (Direct) | View |